Founded in Temple City, California, Fulgent Diagnostics is dedicated to advancing healthcare through specialized genetic testing. The company's core mission is to provide comprehensive and accurate diagnostic solutions that empower patients and healthcare providers. Their services include genetic testing, cancer panel testing, and COVID-19 testing, catering to a diverse market that spans individuals seeking personalized medical insights to large healthcare institutions requiring reliable diagnostic tools.
Fulgent Diagnostics has garnered attention for its innovative approach and robust testing capabilities. Key figures associated with the company include industry experts and investors who have recognized the potential of advanced genetic diagnostics. The company has achieved significant milestones, such as expanding its testing portfolio and playing a crucial role in COVID-19 testing during the pandemic. Overall, Fulgent Diagnostics has made a substantial impact on the medical diagnostics field, contributing to more informed healthcare decisions and improved patient outcomes.
